Interactions of pDCs with Aspergilus
pDC 与曲霉的相互作用
基本信息
- 批准号:8605547
- 负责人:
- 金额:$ 40.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-02-01 至 2017-01-31
- 项目状态:已结题
- 来源:
- 关键词:Acute DiseaseAddressAllergicAnimal ModelAntifungal AgentsApoptosisAspergillosisAspergillus fumigatusAutoimmune DiseasesBacteriaBiologyCD8B1 geneCellsCessation of lifeChelating AgentsChronicDataDendritic CellsDiagnosticEarly treatmentEnvironmentFlow CytometryFundingFungal Drug ResistanceGliotoxinGrowthHost DefenseHumanHyphaeImmuneImmune responseImmune systemImmunocompromised HostImmunologyImmunosuppressive AgentsIn VitroIncubatedInfectionInflammatory ResponseInterferon Type IInterferonsIntravenousKnockout MiceKnowledgeLeadLeukocyte L1 Antigen ComplexLeukocytesLifeLinkLungMaintenanceMediatingMicroscopyModelingMoldsMorbidity - disease rateMusMycosesMycotoxinsNatural Killer CellsNecrosisNeoplasmsNeutropeniaNucleic AcidsPathogenesisPathologyPatientsPattern recognition receptorPersonsPlayPneumoniaPopulationPreventionRoleT-LymphocyteTLR7 geneTNF geneViralVirusZincadaptive immunityarmbasecell typechemokinecytokinedefined contributionfollow-upfungusin vivoin vivo Modelmacrophagemonocytemortalityneutrophilnovel strategiespathogenperipheral bloodpreventpublic health relevancereceptorresponse
项目摘要
DESCRIPTION (provided by applicant): Aspergillus fumigatus is the most common cause of invasive mold infections. Even with advances in therapy and early diagnostics, mortality rates remain high. Plasmacytoid dendritic cells (pDCs) comprise a functionally distinct lineage of DCs that rapidly produce copious amounts of type I interferons (IFNs) upon stimulation with viruses, predominantly via mechanisms dependent on sensing of viral nucleic acids. pDCs link innate to adaptive immunity by secreting cytokines and by priming T cells. The interplay between pDCs and fungi has not been well characterized. The application builds upon compelling preliminary data demonstrating that: 1) human pDCs directly inhibit fungal growth via a mechanism that involves A. fumigatus-induced pDC death; 2) following stimulation with A. fumigatus hyphae, pDCs release cytokines, including type I IFNs; 3) depletion of pDCs renders mice hypersusceptible to pulmonary and intravenous challenge with A. fumigatus by a mechanism that appears to be due, at least in part, to a dysregulated immune response; and 4) pulmonary infection with A. fumigatus results in pDC influx into the lungs. We hypothesize that pDCs play a major role in host defenses against invasive aspergillosis by mediating direct antifungal activity and by modulating the innate and adaptive immune response. To address this hypothesis, we will define the contribution of pDCs in the defense against A. fumigatus using both in vitro and in
vivo models. In Aim 1, we will explore the mechanistic basis of our observations that incubation of pDCs with A. fumigatus in vitro results in fungal recognition, antifungal activity and cytokine release. The receptors required for pDC recognition of the conidial and hyphal fungal morphotypes will be explored. The mechanism of pDC death induced by A. fumigatus will be elucidated. How pDCs mediate antifungal activity will be characterized using both intact pDCs and pDC lysates. Finally, the cytokine and chemokine response of pDCs to A. fumigatus will be investigated. In aim 2, we will follow up our demonstration that pDCs have a non- redundant role in host defenses against aspergillosis by illuminating the mechanisms by which this occurs. The effect of pDC depletion on mortality, fungal burden, immune cell recruitment, pathology and cytokine response will be determined in murine models of invasive aspergillosis. The arms of the immune system required for pDC-mediated protection will be examined by co-depleting pDCs and specific leukocyte subsets and with knockout mice. Lastly, we will determine whether pDCs associate with conidia and hyphae in vivo using flow cytometry and microscopy. Completion of these studies over the funding period will result in major conceptual advances in fungal pathogenesis, fungal immunology and pDC biology. Moreover, the knowledge gained may lead to novel strategies to prevent and treat invasive mycoses.
描述(由申请人提供):烟曲霉是侵入性霉菌感染的最常见原因。即使在治疗和早期诊断方面取得进展,死亡率仍然很高。浆细胞样树突状细胞(pDCs)包括一个功能独特的树突状细胞谱系,它们在病毒刺激下迅速产生大量的I型干扰素(ifn),主要通过依赖于病毒核酸感知的机制。pDCs通过分泌细胞因子和启动T细胞将先天免疫与适应性免疫联系起来。pDCs与真菌之间的相互作用尚未得到很好的表征。该应用程序建立在令人信服的初步数据基础上,这些数据表明:1)人类pDC通过一种涉及烟曲霉诱导pDC死亡的机制直接抑制真菌生长;2)烟曲霉菌丝刺激后,pDCs释放包括I型ifn在内的细胞因子;3) pDCs的消耗使小鼠对烟曲霉肺和静脉攻击易感,其机制似乎是由于,至少部分是由于免疫反应失调;4)肺部感染烟曲霉导致pDC流入肺部。我们假设pDCs通过介导直接抗真菌活性和调节先天和适应性免疫反应,在宿主防御侵袭性曲霉病中发挥重要作用。为了解决这一假设,我们将定义pDCs在体外和体内对烟曲霉的防御中的贡献
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Stuart Michael Levitz其他文献
Stuart Michael Levitz的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Stuart Michael Levitz', 18)}}的其他基金
The contribution of eosinophils and the IL-23/IL-17 axis to host responses to Aspergillus
嗜酸性粒细胞和 IL-23/IL-17 轴对宿主对曲霉反应的贡献
- 批准号:
10163121 - 财政年份:2018
- 资助金额:
$ 40.83万 - 项目类别:
Preclinical studies of a Cryptococcus vaccine for AIDS patients
针对艾滋病患者的隐球菌疫苗的临床前研究
- 批准号:
10259153 - 财政年份:2016
- 资助金额:
$ 40.83万 - 项目类别:
Preclinical studies of a Cryptococcus vaccine for AIDS patients
针对艾滋病患者的隐球菌疫苗的临床前研究
- 批准号:
10557083 - 财政年份:2016
- 资助金额:
$ 40.83万 - 项目类别:
Preclinical studies of a Cryptococcus vaccine for AIDS patients
针对艾滋病患者的隐球菌疫苗的临床前研究
- 批准号:
10598929 - 财政年份:2016
- 资助金额:
$ 40.83万 - 项目类别:
Preclinical studies of a Cryptococcus vaccine for AIDS patients
针对艾滋病患者的隐球菌疫苗的临床前研究
- 批准号:
9140479 - 财政年份:2016
- 资助金额:
$ 40.83万 - 项目类别:
Preclinical studies of a Cryptococcus vaccine for AIDS patients
针对艾滋病患者的隐球菌疫苗的临床前研究
- 批准号:
9222705 - 财政年份:2016
- 资助金额:
$ 40.83万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 40.83万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 40.83万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 40.83万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 40.83万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 40.83万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 40.83万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 40.83万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 40.83万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 40.83万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 40.83万 - 项目类别:
Research Grant














{{item.name}}会员




